Dr. Manali K. Kamdar, MD

Dr. Kamdar practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Kamdar's NPI, 1184817959, was assigned on August 24, 2007. Dr. Kamdar graduated from KJ Somaiya Medical College in 2004. Dr. Kamdar holds Colorado license DR.0054234.

Dr. Kamdar's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Kamdar's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Kamdar is also affiliated with Children's Hospital Colorado Anschutz Medical Campus. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Kamdar to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamdar practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kamdar's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kamdar is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kamdar's licenses on file in 4 states: Colorado, California, Wyoming and North Carolina.

Dmand AI lists chronic leukemia and lymphoma among the conditions Dr. Kamdar treats.

CMS data shows 510 Medicare services from Dr. Kamdar across 4 procedure codes in 2024, for 244 Medicare patients. Medicare paid $44,589 for them.

CMS counts 244 Medicare patients who saw Dr. Kamdar in 2024. The largest group is 65 to 74, with 130 patients. 65% of them have high cholesterol, and 57% have high blood pressure. 9% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kamdar's median patient age at 71, with 41% women.

In 2024, Dr. Kamdar wrote 641 Medicare Part D claims for 103 patients. 54% of them were for generic drugs. CMS names the drug for 508 of them, across 11 drugs with 11 or more claims each, at $3,966,435 in total drug cost. In 2023, CMS named 289 claims across 8 drugs.

Dr. Kamdar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kamdar as offering telehealth.

Dmand AI links 57 papers to Dr. Kamdar, published from 2015 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Large B-Cell, Diffuse and Immunotherapy, Adoptive. Dr. Kamdar has published most often in Blood Adv. Dr. Kamdar's most frequent co-authors are Jeremy S. Abramson, MD, Brad Steven Kahl, MD and Veronika Bachanova, MD.

Dmand AI links Dr. Kamdar to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse and Lymphoma, B-Cell. University of Colorado, Denver sponsors the most, 2.

CMS Open Payments shows 177 general payments to Dr. Kamdar from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Seagen Inc. paid the most, $44,921. It also lists 15 research payments totaling $5,262 from 2017 to 2025.

Dr. Kamdar graduated from KJ Somaiya Medical College in 2004.

Dr. Kamdar is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.